NCT03267927

Brief Summary

Assessment of the association of maxillary expansion using a rapid palatal expansion, use of a mandibular advancement appliance (MGA™) and of a device allowing sleep in a semi-seated position (Yoobreath™) in patients with Obstructive Sleep Apnea (OAS). MGA™ and YooBreath™ constitute the Yookid system™.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 31, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

November 5, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2019

Completed
Last Updated

February 7, 2020

Status Verified

February 1, 2020

Enrollment Period

1.4 years

First QC Date

August 28, 2017

Last Update Submit

February 6, 2020

Conditions

Keywords

OSAPolysomnographyRapid palatal expansionMandibular advancementSleep position

Outcome Measures

Primary Outcomes (2)

  • Assessment in 5 to 7 year-old children the efficacy on OSA (removal or decrease of apnea/hypopnea) of Rapid Palatal Expansion combined with advancement using a mandibular advancement appliance (MGA™)

    Day 180

  • Assessment in 5 to 7 year-old children the efficacy on OSA (removal or decrease of apnea/hypopnea) of Rapid Palatal Expansion combined with a device allowing a semi-seated sleeping position (YooBreath™)

    Day 180

Secondary Outcomes (16)

  • Sleep improvement

    Day -7, day 180

  • Assessment of quality of sleep

    Day 180

  • Assessment of quality of wakefulness

    Day 180

  • Measurement of lengthening of mandibular body and ramus

    Day -7, day 180

  • Improvement of breathing

    Day -7, day 180

  • +11 more secondary outcomes

Study Arms (1)

Patient with OSA

EXPERIMENTAL
Device: Rapid palatal expansionDevice: MGA™ systemDevice: Yoobreath™ system

Interventions

Fixation of rapid palatal expansion from day 0 to day 60

Patient with OSA

Use of a mandibular advancement Appliance during the night from day 60 to day 180 (end of treatment from day 120 if Angle Class I is obtained)

Patient with OSA

Use of a device allowing sleep in a semi-seated position during the night from day 15 to day 180 (end of treatment from day 120 if Angle Class I is obtained)

Patient with OSA

Eligibility Criteria

Age5 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • to 7 year-old children
  • Children with American Society of Anesthesiologists score (ASA) of 1 and 2
  • Children with signs of OSA during examination and clinical exam
  • Children with apnea-hypopnea index (AHI) from 1 to 5 (one to five sleep apnea / hour during PSG)
  • Children with a class II division 1 angle malocclusion (at the canines level rotation center) and skeletal class II according to Delaire analysis

You may not qualify if:

  • OSA associated to syndromic disorder and/or syndrome
  • Body/Mass Index (BMI) \> 97ème percentile according to development curves (obese children)
  • Central sleep apnea
  • Respiratory allergy
  • Previous ear, nose and throat (ENT) surgery
  • Hypertrophic tonsils needing surgery
  • Adenoid hypertrophy needing surgery
  • Patients with ankyloglossia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rennes

Rennes, 35033, France

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2017

First Posted

August 31, 2017

Study Start

November 5, 2017

Primary Completion

March 25, 2019

Study Completion

March 25, 2019

Last Updated

February 7, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations